Implantica announced that the U.S. Food and Drug Administration has granted approval for its RefluxStop implant to treat gastroesophageal reflux disease (GERD). The company did not provide additional procedural or technical details in its initial disclosure.
Further verified specifics about the device’s specifications, commercial launch timing, or regulatory pathway were not immediately available.
